Figure 1. LP-184 shows broad anti-tumor cytotoxicity across a panel of NSCLC derived cell lines.

(A) This bar graph demonstrates the range of NSCLC cell line sensitivity to LP-184, technically performed in triplicate wells (represented in Supplementary Figures 2–10), plotted in terms of nanomolar IC₅₀ on Y axis and respective cell line IDs on X axis. (B) This bar graph demonstrates the sensitivity range of brain metastasis cell lines originating from primary lung cancers to LP-184, technically performed in duplicate wells (represented in Supplementary Figures 11–14), plotted in terms of nanomolar IC₅₀ on Y axis and respective cell line IDs on X axis.